Drug Shortage Report for SODIUM CHLORIDE INJECTION, USP
| Report ID | 138379 |
| Drug Identification Number | 02139510 |
| Brand name | SODIUM CHLORIDE INJECTION, USP |
| Common or Proper name | Sodium Chloride Injection, USP 4 mEq/mL Maxivial® 200 mL |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | SODIUM CHLORIDE |
| Strength(s) | 234MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 200 mL |
| ATC code | B05XA |
| ATC description | I.V. SOLUTION ADDITIVES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2021-05-03 |
| Actual start date | 2021-05-03 |
| Estimated end date | 2021-09-13 |
| Actual end date | 2021-09-15 |
| Shortage status | Resolved |
| Updated date | 2021-09-16 |
| Company comments | Situation is resolved. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2021-04-30 | English | Compare |
| v2 | 2021-04-30 | French | Compare |
| v3 | 2021-05-04 | English | Compare |
| v4 | 2021-07-28 | English | Compare |
| v5 | 2021-07-28 | French | Compare |
| v6 | 2021-08-31 | English | Compare |
| v7 | 2021-08-31 | English | Compare |
| v8 | 2021-08-31 | French | Compare |
| v9 | 2021-09-15 | English | Compare |
| v10 | 2021-09-15 | French | Compare |
| v11 | 2021-09-16 | English | Compare |
Showing 1 to 11 of 11